Total Payments
$85,576
2024 Payments
$5,037
Companies
86
Transactions
1,109
Medicare Patients
2,306
Medicare Billing
$919,714
Payment Breakdown by Category
Other$49,744 (58.1%)
Food & Beverage$22,979 (26.9%)
Research$5,950 (7.0%)
Consulting$4,800 (5.6%)
Travel$1,921 (2.2%)
Education$181.31 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $49,744 | 36 | 58.1% |
| Food and Beverage | $22,979 | 1,044 | 26.9% |
| Unspecified | $5,950 | 6 | 7.0% |
| Consulting Fee | $4,800 | 2 | 5.6% |
| Travel and Lodging | $1,921 | 12 | 2.2% |
| Education | $181.31 | 9 | 0.2% |
Payments by Type
General
$79,626
1,103 transactions
Research
$5,950
6 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $25,984 | 87 | $0 (2024) |
| Allergan, Inc. | $20,863 | 65 | $0 (2022) |
| ABBVIE INC. | $15,913 | 152 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $4,894 | 27 | $0 (2024) |
| UCB, Inc. | $2,006 | 71 | $0 (2024) |
| Medtronic USA, Inc. | $1,830 | 19 | $0 (2020) |
| EMD Serono, Inc. | $838.77 | 51 | $0 (2024) |
| PFIZER INC. | $753.24 | 43 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $623.04 | 36 | $0 (2024) |
| Eisai Inc. | $579.17 | 29 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,037 | 174 | ABBVIE INC. ($1,987) |
| 2023 | $11,632 | 201 | ABBVIE INC. ($7,655) |
| 2022 | $7,917 | 117 | ABBVIE INC. ($5,712) |
| 2021 | $12,567 | 82 | Allergan, Inc. ($11,582) |
| 2020 | $13,449 | 57 | Allergan, Inc. ($8,783) |
| 2019 | $8,620 | 164 | Teva Pharmaceuticals USA, Inc. ($3,937) |
| 2018 | $19,145 | 169 | Teva Pharmaceuticals USA, Inc. ($16,572) |
| 2017 | $7,209 | 145 | Teva Pharmaceuticals USA, Inc. ($4,990) |
All Payment Transactions
1,109 individual payment records from CMS Open Payments — Page 1 of 45
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $23.89 | General |
| Category: NEUROSCIENCE | ||||||
| 12/18/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $26.18 | General |
| Category: Neurology | ||||||
| 12/17/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: Rare Disease | ||||||
| 12/16/2024 | BANNER LIFE SCIENCES, LLC | BAFIERTAM (Drug) | Food and Beverage | In-kind items and services | $31.58 | General |
| Category: Immune | ||||||
| 12/13/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: PAIN | ||||||
| 12/11/2024 | ABBVIE INC. | VYALEV (Drug) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $24.94 | General |
| Category: Neuropsychiatry | ||||||
| 12/08/2024 | PFIZER INC. | PANZYGA (Biological) | Food and Beverage | In-kind items and services | $24.58 | General |
| Category: IMMUNOLOGY;INFLAMMATION | ||||||
| 12/08/2024 | PFIZER INC. | PANZYGA (Biological) | Food and Beverage | In-kind items and services | $2.20 | General |
| Category: IMMUNOLOGY;INFLAMMATION | ||||||
| 12/08/2024 | PFIZER INC. | PANZYGA (Biological) | Food and Beverage | In-kind items and services | $1.96 | General |
| Category: IMMUNOLOGY;INFLAMMATION | ||||||
| 12/06/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $46.53 | General |
| Category: Neurology | ||||||
| 12/06/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $23.89 | General |
| Category: AMANTADINE | ||||||
| 12/05/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: Central Nervous System | ||||||
| 12/04/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $21.63 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/03/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $29.81 | General |
| Category: Musculoskeletal | ||||||
| 12/02/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $24.29 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | Boston Scientific Corporation | Vercise (Device) | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: Vercise_NMD | ||||||
| 11/27/2024 | PFIZER INC. | PANZYGA (Biological) | Food and Beverage | In-kind items and services | $8.85 | General |
| Category: IMMUNOLOGY;INFLAMMATION | ||||||
| 11/25/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/25/2024 | PFIZER INC. | PANZYGA (Biological) | Food and Beverage | In-kind items and services | $8.88 | General |
| Category: IMMUNOLOGY;INFLAMMATION | ||||||
| 11/22/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $14.56 | General |
| 11/21/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $32.66 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $28.73 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/12/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $27.32 | General |
| Category: Immunology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| ACA 16-cAC-0001 | ACADIA Pharmaceuticals Inc | $4,500 | 4 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 560 | 36,970 | $851,529 | $261,901 |
| 2022 | 13 | 586 | 33,238 | $782,624 | $242,939 |
| 2021 | 12 | 595 | 29,888 | $737,823 | $235,640 |
| 2020 | 13 | 565 | 23,436 | $595,107 | $179,234 |
Total Patients
2,306
Total Services
123,532
Medicare Billing
$919,714
Procedure Codes
50
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 49 | 35,969 | $611,473 | $172,622 | 28.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 210 | 385 | $78,155 | $33,520 | 42.9% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2023 | 29 | 93 | $33,108 | $11,562 | 34.9% |
| 64612 | Injection of chemical for paralysis of nerve muscles on side of face | Office | 2023 | 18 | 58 | $28,826 | $8,766 | 30.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 57 | 69 | $18,837 | $8,418 | 44.7% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Office | 2023 | 39 | 117 | $19,422 | $7,454 | 38.4% |
| 64644 | Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, first extremity | Office | 2023 | 11 | 36 | $16,632 | $4,555 | 27.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 54 | 73 | $10,001 | $4,515 | 45.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 31 | 31 | $9,703 | $3,342 | 34.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 18 | 18 | $7,020 | $3,063 | 43.6% |
| 95983 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, first 15 minutes with qualified health professional | Office | 2023 | 30 | 73 | $11,680 | $2,640 | 22.6% |
| 95984 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, each additional 15 minutes with qualified health professional | Office | 2023 | 14 | 48 | $6,672 | $1,445 | 21.7% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 46 | 32,322 | $490,943 | $155,224 | 31.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 205 | 351 | $97,632 | $31,140 | 31.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 74 | 87 | $32,319 | $11,628 | 36.0% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2022 | 26 | 77 | $30,263 | $10,375 | 34.3% |
| 64612 | Injection of chemical for paralysis of nerve muscles on side of face | Office | 2022 | 16 | 47 | $25,459 | $6,330 | 24.9% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Office | 2022 | 33 | 91 | $18,634 | $5,897 | 31.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 48 | 48 | $21,378 | $5,571 | 26.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 69 | 85 | $18,281 | $4,774 | 26.1% |
| 64644 | Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, first extremity | Office | 2022 | 12 | 30 | $14,910 | $4,152 | 27.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 17 | 17 | $9,710 | $2,683 | 27.6% |
| 64642 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity | Office | 2022 | 12 | 25 | $10,844 | $2,169 | 20.0% |
| 64643 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, each additional extremity | Office | 2022 | 11 | 25 | $7,016 | $1,853 | 26.4% |
| 95983 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, first 15 minutes with qualified health professional | Office | 2022 | 17 | 33 | $5,235 | $1,144 | 21.8% |
About Dr. Aaron Haug, M.D
Dr. Aaron Haug, M.D is a Neurology healthcare provider based in Englewood, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/11/2007. The National Provider Identifier (NPI) number assigned to this provider is 1962606467.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Aaron Haug, M.D has received a total of $85,576 in payments from pharmaceutical and medical device companies, with $5,037 received in 2024. These payments were reported across 1,109 transactions from 86 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($49,744).
As a Medicare-enrolled provider, Haug has provided services to 2,306 Medicare beneficiaries, totaling 123,532 services with total Medicare billing of $919,714. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Englewood, CO
- Active Since 06/11/2007
- Last Updated 06/04/2020
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1962606467
Products in Payments
- BOTOX (Biological) $34,522
- AUSTEDO (Drug) $24,703
- NUPLAZID (Drug) $4,894
- UBRELVY (Drug) $815.62
- Briviact (Drug) $709.57
- SD809-TD (Drug) $562.95
- Fycompa (Drug) $544.96
- PANZYGA (Biological) $515.36
- Vimpat (Drug) $474.44
- DUOPA (Drug) $469.94
- QULIPTA (Drug) $462.35
- Aimovig (Biological) $433.57
- SOLIRIS (Biological) $430.06
- Fintepla (Drug) $408.90
- INGREZZA (Drug) $399.56
- APTIOM (Drug) $398.29
- KESIMPTA (Drug) $369.52
- ACTHAR (Biological) $343.25
- VALTOCO (Drug) $336.94
- ACTIVA (Device) $319.87
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Englewood
Dr. Rajeev Kumar, Md, MD
Neurology — Payments: $1.4M
Neurology $1.4M
Dr. Marc Treihaft, Md, MD
Neurology — Payments: $672,184
Neurology $672,184
Beverly Gilder, Md, MD
Neurology — Payments: $666,331
Neurology $666,331
Cori Millen, D.o, D.O
Neurology — Payments: $325,077
Neurology $325,077
Rikki Racela, Md, MD
Neurology — Payments: $134,214
Neurology $134,214
Monique Giroux, Md, MD
Neurology — Payments: $85,901
Neurology $85,901